Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
VBI Vaccines (VBIV)
NASDAQ:VBIV
VBI Vaccines (VBIV) Stock Price & Analysis
2,222 Followers
VBIV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.45 - $1.53
Previous Close$0.76
Volume85.80K
Average Volume (3M)146.26K
Market Cap
$22.57M
Enterprise Value$51.23M
Total Cash (Recent Filing)$23.68M
Total Debt (Recent Filing)$53.04M
Price to Earnings (P/E)―
Beta1.81
Next Earnings
Aug 07, 2024EPS Estimate
-$0.32Last Dividend Ex-Date
Jul 14, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-6.92
Shares Outstanding28,682,275
10 Day Avg. Volume108,337
30 Day Avg. Volume146,259
Standard Deviation0.28
R-Squared0.14
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)-0.96
Price to Sales (P/S)15.85
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.90
Enterprise Value/Gross Profit-13.39
Enterprise Value/Ebitda-1.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VBI Vaccines News
PremiumCompany Announcements
VBI Vaccines Shareholders Approve Board and Accountant
PremiumCompany Announcements
VBI Vaccines Shows Promise in Glioblastoma Trial
PremiumCompany Announcements
VBI Vaccines’ Promising Glioblastoma Treatment Data
PremiumCompany Announcements
VBI Vaccines’ Revenue Soars, Promising Vaccine Trials
PremiumCompany Announcements
VBI Vaccines Updates Share Sale Agreements and Partnerships
PremiumCompany Announcements
VBI Vaccines Soars with Hepatitis B Vaccine SuccessRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VBIV FAQ
What was VBI Vaccines’s price range in the past 12 months?
VBI Vaccines lowest stock price was $0.45 and its highest was $1.53 in the past 12 months.
What is VBI Vaccines’s market cap?
Currently, no data Available
When is VBI Vaccines’s upcoming earnings report date?
VBI Vaccines’s upcoming earnings report date is Aug 07, 2024 which is in 11 days.
How were VBI Vaccines’s earnings last quarter?
Currently, no data Available
Is VBI Vaccines overvalued?
According to Wall Street analysts VBI Vaccines’s price is currently Overvalued.
Does VBI Vaccines pay dividends?
VBI Vaccines pays a Notavailable dividend of $135.6 which represents an annual dividend yield of N/A. See more information on VBI Vaccines dividends here
What is VBI Vaccines’s EPS estimate?
VBI Vaccines’s EPS estimate is -$0.32.
How many shares outstanding does VBI Vaccines have?
VBI Vaccines has 28,682,276 shares outstanding.
What happened to VBI Vaccines’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VBI Vaccines?
Among the largest hedge funds holding VBI Vaccines’s share is Perceptive Advisors LLC. It holds VBI Vaccines’s shares valued at 760K.
---
VBI Vaccines Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 119.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-42.97%
12-Months-Change
Fundamentals
Return on Equity
-419.59%
Trailing 12-Months
Asset Growth
-41.27%
Trailing 12-Months
Company Description
VBI Vaccines
VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA.
---
VBIV Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---